{"id":"https://openalex.org/W7220446342","doi":"https://doi.org/10.7759/cureus.117500","title":"GLP-1 Receptor Agonists Across the Coronary Disease Continuum in Type 2 Diabetes: A Systematic Review of Ischemic Events, Revascularization, and Stent Healing","display_name":"GLP-1 Receptor Agonists Across the Coronary Disease Continuum in Type 2 Diabetes: A Systematic Review of Ischemic Events, Revascularization, and Stent Healing","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7220446342","doi":"https://doi.org/10.7759/cureus.117500","pmid":"https://pubmed.ncbi.nlm.nih.gov/42985248","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13734674"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117500","doi":"https://doi.org/10.7759/cureus.117500","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117500","pdf_url":"https://www.cureus.com/articles/530082-glp-1-receptor-agonists-across-the-coronary-disease-continuum-in-type-2-diabetes-a-systematic-review-of-ischemic-events-revascularization-and-stent-healing.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/530082-glp-1-receptor-agonists-across-the-coronary-disease-continuum-in-type-2-diabetes-a-systematic-review-of-ischemic-events-revascularization-and-stent-healing.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157400473","display_name":"Batool I Abuzenah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114972647","display_name":"University of Jordan","ror":"https://ror.org/05k89ew48","country_code":"JO","type":"education","lineage":["https://openalex.org/I114972647"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Batool I Abuzenah","raw_affiliation_strings":["School of Pharmacy, University of Jordan, Amman, JOR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Jordan, Amman, JOR","institution_ids":["https://openalex.org/I114972647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124875286","display_name":"Hebah Abuzenah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104941359","display_name":"Al-Ahliyya Amman University","ror":"https://ror.org/00xddhq60","country_code":"JO","type":"education","lineage":["https://openalex.org/I104941359"]}],"countries":["JO"],"is_corresponding":false,"raw_author_name":"Hebah Abuzenah","raw_affiliation_strings":["School of Pharmacy, Al-Ahliyya Amman University, Amman, JOR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Al-Ahliyya Amman University, Amman, JOR","institution_ids":["https://openalex.org/I104941359"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100282346","display_name":"Mohammad Abuzenah","orcid":"https://orcid.org/0000-0001-6235-4611","observed_orcids":["https://orcid.org/0000-0001-6235-4611"]},"institutions":[{"id":"https://openalex.org/I4405259061","display_name":"Northern Care Alliance NHS Foundation Trust","ror":"https://ror.org/01nqeyn25","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mohammad Abuzenah","raw_affiliation_strings":["Internal Medicine, Northern Care Alliance NHS Foundation Trust, Salford, GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Northern Care Alliance NHS Foundation Trust, Salford, GBR","institution_ids":["https://openalex.org/I4405259061"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100282346"],"corresponding_institution_ids":["https://openalex.org/I4405259061"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.53526877,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10","first_page":"e117500","last_page":"e117500"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9919999837875366},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.8270000219345093},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.996999979019165},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/coronary-revascularization","display_name":"coronary revascularization","score":0.9869999885559082},{"id":"https://openalex.org/keywords/percutaneous-coronary-intervention","display_name":"percutaneous coronary intervention","score":0.9769999980926514},{"id":"https://openalex.org/keywords/stent-healing","display_name":"stent healing","score":0.9570000171661377},{"id":"https://openalex.org/keywords/epicardial-adipose-tissue","display_name":"epicardial adipose tissue","score":0.878000020980835},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.8090000152587891},{"id":"https://openalex.org/keywords/efpeglenatide","display_name":"efpeglenatide","score":0.921999990940094},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9800999760627747},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6879000067710876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6622999906539917},{"id":"https://openalex.org/C2778583881","wikidata":"https://www.wikidata.org/wiki/Q1325542","display_name":"Stent","level":2,"score":0.4984999895095825},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.4562999904155731},{"id":"https://openalex.org/C2780911114","wikidata":"https://www.wikidata.org/wiki/Q14523941","display_name":"Coronary stent","level":4,"score":0.4406000077724457},{"id":"https://openalex.org/C2994432733","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary disease","level":3,"score":0.4343000054359436},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4047999978065491},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.38670000433921814},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.34439998865127563},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3440000116825104},{"id":"https://openalex.org/C2992464422","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Coronary stenting","level":4,"score":0.33980000019073486},{"id":"https://openalex.org/C3018906752","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary heart disease","level":2,"score":0.2854999899864197},{"id":"https://openalex.org/C3019004856","wikidata":"https://www.wikidata.org/wiki/Q42297149","display_name":"Coronary angiography","level":3,"score":0.2847000062465668},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.26969999074935913}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.117500","doi":"https://doi.org/10.7759/cureus.117500","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117500","pdf_url":"https://www.cureus.com/articles/530082-glp-1-receptor-agonists-across-the-coronary-disease-continuum-in-type-2-diabetes-a-systematic-review-of-ischemic-events-revascularization-and-stent-healing.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13734674","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13734674/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13734674/pdf/cureus-0018-00000117500.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:42985248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42985248","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.117500","doi":"https://doi.org/10.7759/cureus.117500","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117500","pdf_url":"https://www.cureus.com/articles/530082-glp-1-receptor-agonists-across-the-coronary-disease-continuum-in-type-2-diabetes-a-systematic-review-of-ischemic-events-revascularization-and-stent-healing.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220446342.pdf","grobid_xml":"https://content.openalex.org/works/W7220446342.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1971101640","https://openalex.org/W2970684805","https://openalex.org/W3021856094","https://openalex.org/W3118615836","https://openalex.org/W3165372948","https://openalex.org/W3195404919","https://openalex.org/W4200205471","https://openalex.org/W4213096040","https://openalex.org/W4296802076","https://openalex.org/W4321374183","https://openalex.org/W4388831896","https://openalex.org/W4389473678","https://openalex.org/W4391211868","https://openalex.org/W4391747498","https://openalex.org/W4401699467","https://openalex.org/W4402050123","https://openalex.org/W4404114247","https://openalex.org/W4405861734","https://openalex.org/W7164986971"],"related_works":["https://openalex.org/W4323037505","https://openalex.org/W4282935470","https://openalex.org/W4413803897","https://openalex.org/W3216023807","https://openalex.org/W7166867211","https://openalex.org/W4403813015","https://openalex.org/W4416579958","https://openalex.org/W4410011775","https://openalex.org/W4280635291","https://openalex.org/W3007686565"],"abstract_inverted_index":{"Type":[0],"2":[1,195],"diabetes":[2],"is":[3],"associated":[4,241],"with":[5,123,235,242,250],"accelerated":[6],"coronary":[7,18,33,49,52,60,278,349,384],"atherosclerosis,":[8],"recurrent":[9,188],"ischemic":[10],"events,":[11,196],"and":[12,56,71,131,166,176,187,193,223,259,280,343,369,377,391],"impaired":[13],"vascular":[14],"healing":[15],"after":[16],"percutaneous":[17],"intervention":[19],"(PCI);":[20],"however,":[21],"the":[22,72,124,179,207,225,251,271,281,299,334,355],"effects":[23],"of":[24,59,67,76,162,227,245,273,311,320,358,371],"glucagon-like":[25],"peptide-1":[26],"(GLP-1)":[27],"receptor":[28],"agonists":[29],"across":[30],"these":[31],"distinct":[32],"outcomes":[34,261],"remain":[35],"incompletely":[36],"characterized.":[37],"This":[38],"systematic":[39],"review":[40,118],"synthesized":[41,182],"randomized":[42,143,156,164],"evidence":[43],"on":[44,101,362],"myocardial":[45],"infarction":[46],"(MI),":[47],"acute":[48],"syndrome":[50],"(ACS),":[51],"revascularization,":[53,279],"post-PCI":[54],"healing,":[55],"mechanistic":[57],"markers":[58],"disease.":[61,238],"MEDLINE":[62],"via":[63],"PubMed,":[64],"Scopus,":[65],"Web":[66],"Science":[68],"Core":[69],"Collection,":[70],"Cochrane":[73],"Central":[74],"Register":[75],"Controlled":[77],"Trials":[78],"(CENTRAL)":[79],"were":[80,99,115,148,159,168,181,262,338],"initially":[81],"searched":[82],"for":[83,128,275,341,348],"eligible":[84,113,137],"reports":[85,114,138],"published":[86],"from":[87,140,154],"January":[88],"1,":[89],"2020,":[90],"through":[91,108],"December":[92],"31,":[93,103],"2025.":[94],"All":[95],"four":[96],"database":[97],"searches":[98],"updated":[100],"August":[102],"2026,":[104],"extending":[105],"publication":[106],"eligibility":[107],"that":[109],"date;":[110],"no":[111,286],"additional":[112],"identified.":[116],"The":[117],"was":[119,240,304],"conducted":[120],"in":[121,233,289],"accordance":[122],"Preferred":[125],"Reporting":[126],"Items":[127],"Systematic":[129],"Reviews":[130],"Meta-Analyses":[132],"(PRISMA)":[133],"2020":[134],"statement.":[135],"Seven":[136],"derived":[139],"seven":[141,300],"parent":[142,163],"trials,":[144,157,165],"involving":[145],"37,033":[146],"participants,":[147],"included.":[149],"Two":[150],"presented":[151],"primary":[152],"findings":[153,180,337],"independent":[155],"three":[158],"prespecified":[160],"analyses":[161],"two":[167],"post":[169,321,366],"hoc":[170,322,367],"analyses.":[171],"Owing":[172],"to":[173,306],"substantial":[174],"clinical":[175],"outcome":[177],"heterogeneity,":[178],"narratively.":[183],"Albiglutide":[184],"reduced":[185,224],"first":[186],"MI,":[189,230],"including":[190],"type":[191,194],"1":[192],"whereas":[197,313],"higher-dose":[198],"efpeglenatide":[199],"yielded":[200],"more":[201,339],"favorable":[202,340],"cardiovascular":[203,228,247,345],"effect":[204],"estimates":[205],"than":[206,347],"lower":[208,243],"dose.":[209],"Across":[210,333],"separate":[211],"reports,":[212,302,336,360],"semaglutide":[213],"favorably":[214],"modified":[215],"epicardial":[216],"adipose":[217],"tissue,":[218],"a":[219,308,381],"surrogate":[220],"imaging":[221,331],"measure,":[222],"composite":[226,272],"death,":[229],"or":[231,277,295,329,351,365],"stroke":[232],"patients":[234],"diabetic":[236],"kidney":[237],"Liraglutide":[239],"risks":[244],"broader":[246,344],"composites":[248],"compared":[249],"other":[252],"glucose-lowering":[253],"therapies":[254],"combined,":[255],"although":[256],"individual":[257],"MI":[258,342],"revascularization":[260,350],"not":[263,268,379],"significantly":[264,269],"reduced.":[265],"Exenatide":[266],"did":[267],"reduce":[270],"hospitalization":[274],"ACS":[276],"only":[282],"PCI-specific":[283],"trial":[284],"demonstrated":[285],"significant":[287],"improvement":[288],"early":[290],"stent":[291],"coverage,":[292],"neointimal":[293],"thickness,":[294],"in-stent":[296],"obstruction.":[297],"Of":[298],"included":[301,335],"one":[303],"judged":[305],"have":[307],"low":[309],"risk":[310],"bias,":[312],"six":[314],"raised":[315],"some":[316],"concerns,":[317],"primarily":[318],"because":[319],"analyses,":[323,368],"open-label":[324],"treatment,":[325],"incomplete":[326],"methodological":[327],"reporting,":[328],"limited":[330],"follow-up.":[332],"events":[346],"post-stent":[352],"healing.":[353],"However,":[354],"small":[356],"number":[357],"heterogeneous":[359],"reliance":[361],"several":[363],"secondary":[364],"absence":[370],"quantitative":[372],"meta-analysis":[373],"limit":[374],"firm":[375],"conclusions":[376],"do":[378],"establish":[380],"definitive":[382],"class-wide":[383],"effect.":[385],"Potential":[386],"differences":[387],"by":[388],"agent,":[389],"dose,":[390],"patient":[392],"phenotype":[393],"require":[394],"further":[395],"investigation,":[396],"while":[397],"treatment-initiation":[398],"timing":[399],"remains":[400],"largely":[401],"untested.":[402]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-06T00:00:00"}